KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,300 | -42.8% | 55 | -26.7% | 0.01% | -33.3% |
| Q2 2023 | $16,264 | +19.4% | 75 | 0.0% | 0.01% | +9.1% |
| Q1 2023 | $13,623 | -7.6% | 75 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $14,738 | -13.3% | 75 | 0.0% | 0.01% | -26.7% |
| Q3 2022 | $17,000 | +88.9% | 75 | 0.0% | 0.02% | +114.3% |
| Q2 2022 | $9,000 | -10.0% | 75 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $10,000 | 0.0% | 75 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $10,000 | -60.0% | 75 | -63.4% | 0.01% | -66.7% |
| Q3 2021 | $25,000 | +19.0% | 205 | +9.6% | 0.02% | +20.0% |
| Q2 2021 | $21,000 | +5.0% | 187 | +10.0% | 0.02% | -6.2% |
| Q1 2021 | $20,000 | – | 170 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |